- Fast & Precise: 120 tests/hour, results in 30 minutes, <3.5% CV accuracy
- Flexible: 36 analytes, 24 at once, STAT-ready, non-stop loading
- Versatile: Oncology to neurology, CE-marked, FDA-pending assays
| Technology | Chemiluminescent Enzyme Immunoassay (CLEIA) |
|---|---|
| Throughput | 120 tests per hour (true throughput) |
| Time to First Result | ~30 minutes; subsequent results every minute |
| Sample Capacity | 36 analytes on board; 24 measurable simultaneously per sample |
| Assay Type | Mono-test cartridge system |
| Flexibility | Continuous access for samples, reagents, consumables; STAT priority loading |
| Connectivity | Bi-directional LIS integration; compatible with specimen conveyor lines |
| User Features | Disposable pipette tips, master calibration, replenishable wash/substrate solutions |
| Operating Temperature | 15–30°C (typical laboratory conditions) |
| Assay Menu | Oncology (e.g., CA125, HE4), Infectious Diseases (e.g., SARS-CoV-2 Ag), Endocrinology, Metabolic, Neurology |
| Intended Use | Quantitative/qualitative IVD measurement in human specimens (serum, plasma, CSF) |
| Precision | Total imprecision <3.5% CV (e.g., HBV markers, aldosterone) |
| Regulatory Status | CE-marked (Europe); select assays FDA-approved/pending (e.g., pTau 217, filed Sept 2024) |
No products are currently available in this category.
